Literature DB >> 29702008

Natural History over 8 Years of Pulmonary Vascular Disease in a Patient Carrying Biallelic EIF2AK4 Mutations.

David Montani1,2, Peter Dorfmüller1,2, Barbara Girerd1,2, Jérome Le Pavec1,3, Elie Fadel1,3, Gérald Simonneau1,2, Olivier Sitbon1,2, Marc Humbert1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29702008     DOI： 10.1164/rccm.201802-0317LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

1.  Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.

Authors:  Bradley A Maron; Steven H Abman; C Greg Elliott; Robert P Frantz; Rachel K Hopper; Evelyn M Horn; Mark R Nicolls; Oksana A Shlobin; Sanjiv J Shah; Gabor Kovacs; Horst Olschewski; Erika B Rosenzweig
Journal:  Am J Respir Crit Care Med       Date:  2021-06-15       Impact factor: 30.528

2.  Rapid disease progress in a PVOD patient carrying a novel EIF2AK4 mutation: a case report.

Authors:  Xiaofang Zeng; Fan Chen; Anandharajan Rathinasabapathy; Tangzhiming Li; Agila Adnan Ali Mohammed Mohammed; Zaixin Yu
Journal:  BMC Pulm Med       Date:  2020-07-06       Impact factor: 3.317

3.  Screening strategies for pulmonary arterial hypertension.

Authors:  David G Kiely; Allan Lawrie; Marc Humbert
Journal:  Eur Heart J Suppl       Date:  2019-12-17       Impact factor: 1.803

4.  Progression of pulmonary veno-occlusive disease without pulmonary hypertension.

Authors:  Sarah Beshay; Marc Humbert; Roberto Barrios; Sandeep Sahay
Journal:  Pulm Circ       Date:  2022-02-21       Impact factor: 2.886
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.